US FDA okays Taro's generic meloxicam tabs (PharmaBiz)
Taro Pharmaceutical Industries Ltd. has received approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Meloxicam tablets, 7.5 mg and 15 mg.

Ranbaxy Granted Favorable Decision by the U.S. Court of Appeals Regarding Marketing Exclusivity for Simvastatin 80mg (PR Newswire via Yahoo! Finance)
Ranbaxy Laboratories Limited today announced that the U.S. Court of Appeals for the District of Columbia Circuit has affirmed an earlier District Circuit holding on Simvastatin, preserving 180-day exclusivity when patents are delisted from the FDA Orange Book.